Ani Pharmaceuticals Inc (ANIP)
Revenue Growth
25.87%
Quarterly · Period ending:
ANIP Revenue Growth
Year-over-year change vs the same period a year earlier
Latest reported25.87%period ending
Latest reported25.87%period ending
ANIP Quarterly Revenue YoY % (-100.00% → 25.87%)
Year-over-year change
High-resolution chart · PNG
ANIP revenue growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue Growth |
|---|---|
| 25.8659% | |
| 20.4645% | |
| 29.6399% | |
| 53.5832% | |
| 53.123% | |
| 43.4345% | |
| 44.7537% | |
| 12.5185% | |
| 18.4415% | |
| 28.6966% | |
| 39.7126% | |
| 57.2744% | |
| 57.8052% | |
| 65.6187% | |
| 54.6587% | |
| 61.0054% | |
| 51.8869% | |
| 18.2609% | |
| 6.4225% | |
| -1.7328% | |
| 0.3198% | |
| 9.5371% | |
| 19.3595% | |
| 3.1985% | |
| -10.8303% | |
| -5.8861% | |
| -16.0289% | |
| 1.2504% | |
| 14.9975% | |
| 13.7771% | |
| 20.8011% | |
| 5.2716% | |
| 5.5938% | |
| 26.9056% | |
| 23.7691% | |
| 25.0201% | |
| 42.8471% | |
| 78.1951% | |
| 111.8381% | |
| 92.8951% | |
| 60.5708% | |
| 9.3409% | |
| -14.2701% | |
| 14.8674% | |
| 193.6061% | |
| 72.4837% | |
| 99.7436% | |
| 121.8799% | |
| 8.0543% | |
| 7,414.4788% | |
| 435.2787% | |
| 6,999.1203% | |
| 5,555.0276% | |
| 27.2281% | |
| 1,620.3125% | |
| -39.6101% | |
| 34.2913% | |
| 100% | |
| -20.0368% | |
| 256.0889% | |
| -97.4999% | |
| -86.5568% | |
| 389.2394% | |
| -100% | |
| 3,231.7852% | |
| -70.5251% | |
| -87.2379% | |
| 345.1776% | |
| 50.0713% | |
| 996.4989% | |
| 87.7286% | |
| -62.7495% | |
| -9.9016% | |
| -97.6549% | |
| -68.7915% | |
| -60.3734% | |
| -40.2355% | |
| 14,376.8714% | |
| 61.0957% | |
| 284.3561% | |
| 195.2854% | |
| 76.8511% | |
| 709.3849% | |
| 816.3183% | |
| 291.9765% | |
| 198.4275% | |
| -57.6283% | |
| -91.3228% | |
| -103.0254% | |
| -97.3613% | |
| 202.3965% | |
| -44.9145% | |
| -100% |